Advertisement

Nonoperative Treatment of Renal Cell Carcinoma

  • R.-D. Müller
  • E. Scherer
  • C. Wirtz

Abstract

Nonoperative treatment of hypernephroma comprises irradiation and transfemoral catheter embolization of advanced, inoperable, and symptomatic primary tumors; as well as chemotherapy for metastases, using cytostatic substances, hormones, and immunotherapeutic agents.

Keywords

Renal Cell Carcinoma Nonoperative Treatment Preoperative Irradiation Renal Carcinoma Renal Capsule 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abbatucci J-S, Quint R, Bloquel J, Roussel A, Urbajtel M (1976) Techniken der kurativen Telekobalttherapie. Enke StuttgartGoogle Scholar
  2. 2.
    Andersson L, Edsmyr F (1982) Pre- and postoperative radiotherapy, influence on prognosis. Prog Clin Biol Res 100: 609PubMedGoogle Scholar
  3. 3.
    Andreew A, Ranft R, Templin R (1971) Auswertung von 75 Patienten mit einem hypernephroiden Nierenkarzinom. Zentralbl Chir 43: 1487Google Scholar
  4. 4.
    Arner O, Blanck C, von Schreeb T (1965) Renal adenocarcinoma: morphology — grading of malignancy — prognosis. Acta Chir Scand 346 (Suppl): 1Google Scholar
  5. 5.
    Baisch H (1984) Flußzytometrische Untersuchungen des DNA-Gehaltes und der Proliferationskinetik menschlicher Tumoren. Strahlentherapie 160: 431PubMedGoogle Scholar
  6. 6.
    Bennington JL, Kradjian RM (1967) Renal carcinoma. Saunders, PhiladelphiaGoogle Scholar
  7. 7.
    Bischoff W, Sommerkamp H (1977) Zur Problematik der operativen Therapie maligner Nierentumoren. Schweiz Med Wochenschr 107: 699PubMedGoogle Scholar
  8. 8.
    Bloom HJG, Baker WH, Duke CE, Mitchley BC (1963) Hormone dependent tumors of the kidney. II. Effect of endocrine ablation procedure on the transplanted estrogen-induced renal tumors of the Syrian hamster. Br J Cancer 17: 646PubMedCrossRefGoogle Scholar
  9. 9.
    Bloom HJG, Roe F, Mitchley B (1967) Sex hormones and renal neoplasia. Inhibition of tumor of hamster-kidney by an estrogen antagonist. An agent of possible therapeutic value in man. Cancer 20: 2118PubMedCrossRefGoogle Scholar
  10. 10.
    Bloom HJG, Wallace DM (1971) Tumors of the urinary tract. In: Zuppinger A, Krokowski E (eds) Handbuch der medizinischen Radiologic. Spezielle Strahlentherapie maligner Tumoren, vol 19, part 3. Springer, Berlin Heidelberg New York, p. 399Google Scholar
  11. 11.
    Bodey CP (1979) Current status of chemotherapy in metastatic renal carcinoma. In: Johnson DE, Samuels MC (eds) Cancer of the genitourinary tract. Raven, New YorkGoogle Scholar
  12. 12.
    Boeminghaus F, Greipel V, Schwartmann KP (1982) Analyse der Langzeitergebnisse nach Nephrektomie wegen Hypernephrom anhand von 442 Fällen. Urologe A 21: 201PubMedGoogle Scholar
  13. 13.
    Bostel F, Kuhne-Velte HJ, Wöllgens P (1983) Wertigkeit der Strahlentherapie bei Metastasen des hypernephroiden Karzinoms. Strahlentherapie 159: 404PubMedGoogle Scholar
  14. 14.
    Bostel F, Kuhne-Velte HJ, Wöllgens P (1984) 12 Jahre Überlebenszeit eines Patienten mit metastasiertem Hypernephrom unter palliativer Schmerztherapie. Akt Urol 15: 88CrossRefGoogle Scholar
  15. 15.
    Boxer RJ, Waisman J, Lieber MM, Mampaso FM, Skinner DG (1979) Renal carcinoma: computer analysis of 96 patients treated by nephrectomy. J Urol 122: 598PubMedGoogle Scholar
  16. 16.
    Bratherton DG (1964) Tumours of the kidneys and suprarenals. III. The place of radiotherapy in the treatment of hypernephroma. Br J Radiol 37: 141PubMedCrossRefGoogle Scholar
  17. 17.
    Brosig W, Baumgärtel H, Oeser H (1971) Die präoperative Bestrahlung der Nierentumoren aus chirurgischurologischer Sicht. In: Hug O (ed) Präoperative Tumorbestrahlung. Vorträge vom Deutschen Röntgenkongreß 1970. Sonderbande zur Strahlentherapie, vol 71. Urban and Schwarzenberg, München, p 84Google Scholar
  18. 18.
    Brühl P, Scheef W, Albert H, Bücheler E (1975) Therapie und Prognose des hypernephroiden Nierenkarzinoms. Med Klin 70: 873PubMedGoogle Scholar
  19. 19.
    Brühl P, Vahlensieck W, Höfer-Janker H, Scheef W, Thelen M (1976) Das hypernephroide Nierenkarzinom. Aktuel Nephrol 1: 97Google Scholar
  20. 20.
    Buschke F, Parker RG (1972) Radiation therapy in cancer management. Grune and Stratton, New YorkGoogle Scholar
  21. 21.
    Callahan SK, Knight WA, Murphy A (1981) A phase II trial of methyl-glyoxal bisguanylhydrazone (MGBG, methyl GAG) in renal carcinoma. Proc Am Assoc Cancer Res Am Soc Clin Oncol, (Abstract 649) 22: 164Google Scholar
  22. 22.
    Carl P, Rabes H, Eisenberger F, Schmidt P (1974) Autoradiographische Untersuchungen zur DNS-Synthese bestrahlter und nichtbestrahlter Nierenkarzinome bei normothermer Perfusion. Verh Dtsch Ges Urol, 26. Tagung. Springer, Berlin Heidelberg New York, p 176Google Scholar
  23. 23.
    Cavanaugh PJ (1967) Adjunctive radiotherapy in renal carcinoma of adults. In: King JS (ed) Renal neoplasia. Little and Brown, Boston, p 559Google Scholar
  24. 24.
    Cinqualbre J, Goldschmidt P, Bollack C (1982) Le can cer du rein. A propos d’une serie de 230 cas. Sem Hop Paris 58: 812PubMedGoogle Scholar
  25. 25.
    Day JW, Shrivastav S, Lin G, Bonar RA, Paulson DF (1981) In vitro chemotherapeutic testing of urologic tumors. J Urol 125: 490PubMedGoogle Scholar
  26. 26.
    Egger B, Hartung R, Pollak E (1979) Staging und therapeutische Ergebnisse bei 288 hyper-nephroiden Nierenkarzinomen. Med Welt 30: 920PubMedGoogle Scholar
  27. 27.
    Finney R (1973) The value of radiotherapy in the treatment of hypernephroma — a clinical trial. Br J Urol 45: 258PubMedCrossRefGoogle Scholar
  28. 28.
    Finney R (1973) An evaluation of postoperative radio-therapy in hypernephroma treatment — a clinical trial. Cancer 32: 1332CrossRefGoogle Scholar
  29. 29.
    Firusian N (1978) Endoossale Isotopentherapie maligner Skeletterkrankungen. Z Krebsforsch 91: 143CrossRefGoogle Scholar
  30. 30.
    Flamm J, Wober L (1981) Der maligne Nierentumor. Wien Med Wochenschr 23 /24: 579Google Scholar
  31. 31.
    Flocks RH, Kadesky MC (1958) Malignant neoplasms of the kidney: an analysis of 353 patients followed five years or more. J Urol 79: 196PubMedGoogle Scholar
  32. 32.
    Fossa SD, Kjolseth I, Lund G (1982) Radiotherapy of metastases from renal cancer. Eur Urol 8: 340PubMedGoogle Scholar
  33. 33.
    Freed SZ, Halperin JP, Gordon M (1977) Idiopathic regression of metastases from renal cell carcinoma. J Urol 118: 538PubMedGoogle Scholar
  34. 34.
    Fuhrmann SA, Lasky LL, Limas L (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6 (7): 655CrossRefGoogle Scholar
  35. 35.
    Fuselier HA, Guice SL, Brannan W, Ochsner MG, Sangisetty KV, Beckman EN, Barnes CA (1983) Renal cell carcinoma: the Ochsner Medical Institution experience (1945-1978). J Urol 130: 445PubMedGoogle Scholar
  36. 36.
    Garnick MB (1981) Advanced renal cell cancer (nephrology forum). Kidney Int 20: 127CrossRefGoogle Scholar
  37. 37.
    Gauwerky F, Adam K (1971) Die Rolle der Radiotherapie bei der Behandlung der malignen Nierentumoren Erwachsener. Strahlentherapie 142: 629PubMedGoogle Scholar
  38. 38.
    Gauwerky F (1973) Strahlenhandlung von Nierentumoren Erwachsener. Dtsch Aerztebl 70: 275Google Scholar
  39. 39.
    Giuliani L, Martorana G, Giberti C, Pescatore D, Magnani G (1983) Results of radical nephrectomy with extensive lymphadenectomy for renal cell carcinoma. J Urol 129: 664Google Scholar
  40. 40.
    Grawitz PA (1883) Die sogenannten Lipome der Niere. Arch Pathol Anat 93: 39CrossRefGoogle Scholar
  41. 41.
    Halperin EC, Harisiadis L (1983) The role of radiation therapy in the management of metastatic renal cell carcinoma. Cancer 51: 614PubMedCrossRefGoogle Scholar
  42. 42.
    Hermanek P, Sigel A, Chlepas S (1976) Histological grading of renal cell carcinoma. Eur Urol 2: 189PubMedGoogle Scholar
  43. 43.
    Herrlinger A, Sigel A, Schrott KM (1982) Die Bedeutung der lymphogenen Metastasierung des Nierencar- cinoms fur das Vorgehen bei der radikalen Tumorneph- rektomie. Verh Dtsch Ges Urol 34. Tagung. Springer, Berlin Heidelberg New York, p 104Google Scholar
  44. 44.
    Herrlinger A, Sigel A, Giedl J (1984) Methodik der radikalen transabdominalen Tumornephrektomie mit fakultativer oder systematischer Lymphdissektion und deren Ergebnisse an 381 Patienten. Urologe A 23: 267PubMedGoogle Scholar
  45. 45.
    Higer HP (1981) Risikofaktoren für Folgeerkrankungen der Hypernephromtherapie. Strahlentherapie 157: 633PubMedGoogle Scholar
  46. 46.
    von Hoff DD, Casper J, Bradley E, Sandbach J, Makuch R (1981) Association between human tumor colony-forming assay results and response in individual patient’s tumor to chemotherapy. Am J Med 70: 1027CrossRefGoogle Scholar
  47. 47.
    Hohenberg G (1983) Postoperative Radiotherapie beim hypernephroiden Karzinom — Auswertung von 63 Fallen. Urologe B 23: 323Google Scholar
  48. 48.
    Hop WCJ, van der Werf-Messing BHP (1980) Prognostic indexes for renal cell carcinoma. Eur J Cancer 16: 833PubMedGoogle Scholar
  49. 49.
    Hrushesky WJ, Murphy GP (1974) Evaluation of chemotherapeutic agents in a new murine carcinoma model. J Natl Cancer Inst 52: 1117PubMedGoogle Scholar
  50. 50.
    Hrushesky WJ, Murphy GP (1977) Current status of the therapy of advanced renal carcinoma. J Surg Oncol 9: 277PubMedCrossRefGoogle Scholar
  51. 51.
    Huber H, Husslein P, Michalica W, Wagenbichler P (1984) Radiosensitizing effect of medroxyprogesterone acetate on endometrial cancer cells in vitro. Cancer 54: 999PubMedCrossRefGoogle Scholar
  52. 52.
    Hudgins PT, Collins VP (1966) Radiotherapy for renal adenocarcinoma. Am J Roentgenol 96: 620Google Scholar
  53. 53.
    Hübener K-H, Eibach E (1977) Strahlentherapie des Nierenkarzinoms — Untersuchungen und Ergebnisse. Strahlentherapie 153: 726PubMedGoogle Scholar
  54. 54.
    Hübener K-H, Junker A (1979) Vergleichende Bestrahlungsplanung mit konventioneller röntgendiagnostischer und computertomographischer Technik bei Nieren- und Harnblasenkarzinomen. Strahlentherapie 155: 376PubMedGoogle Scholar
  55. 55.
    Hug O (1971) Strahlenbiologische Begründung, Methoden und Aussichten einer praoperativen Tumorbestrahlung. Zusammenfassung und Schlußwort. In: Hug O (ed) Präoperative Tumorbestrahlung. Vorträge vom Deutschen Rontgenkongreß 1970. Sonderbaende zur Strahlentherapie, vol 71. Urban and Schwarzenberg, München, p 115Google Scholar
  56. 56.
    Ishmael DR, Burpo LJ, Bottomley RH (1978) Combined therapy of advanced hypernephroma with medroxy-progesterone, BCG, adriamycin and vincristine. Abstract Proc Amer Soc Clin Oncol 19: 407Google Scholar
  57. 57.
    Javadpour N (1984) Surgical management of renal cancer. In: Javadpour N (ed) Cancer of the kidney. Thieme-Stratton, New York, p 69Google Scholar
  58. 58.
    Jones GW (1982) Renal cell carcinoma. CA 32: 280PubMedGoogle Scholar
  59. 59.
    Juusela H, Malmio K, Alfthan O, Oravisto KJ (1977) Preoperative irradiation in the treatment of renal adenocarcinoma. Scand J Urol Nephrol 11: 277PubMedCrossRefGoogle Scholar
  60. 60.
    Juusela H (1978) Renal adenocarcinoma: clinical features and factors correlating to survival in 173 patients. Ann Chir Gynaecol Fenniae 67 suppl 193: 1Google Scholar
  61. 61.
    Kantor AF (1977) Current concepts in the epidemiology and etiology of primary renal cell carcinoma. J Urol 117: 415PubMedGoogle Scholar
  62. 62.
    Katakkar SB, Franks CR (1978) Chemo-hormonal therapy for metastatic renal cell carcinoma with adriamycin, hydroxyurea, vinblastine and medroxy-progesterone acetate. Cancer Treat Rep 62: 1379PubMedGoogle Scholar
  63. 63.
    de Kernion JB, Berry D (1980) The diagnosis and treatment of renal cell carcinoma. Cancer 45: 1947Google Scholar
  64. 64.
    de Kernion JB (1983) Treatment of advanced renal cell carcinoma — traditional methods and innovative ap-proaches. J Urol 130: 2Google Scholar
  65. 65.
    Knight WA, Livingston RB, Fabian C, Costanzi J (1979) Methyl-gloxal bisguanylhydrazone (methyl GAG, MGBG) in advanced human malignancy. Proc Amer Ass Cancer Res Amer Soc Clin Oncol (Abstract C-115) 20: 319Google Scholar
  66. 66.
    Kob D, Arndt J, Klötzer K-H, Stecher M, Kriester A (1974) Ergebnisse der Therapie von bösartigen Nierentumoren mit der ultraharten Bremsstrahlung eines 30-MeV-Betatron. Radiobiol Radiother (Berl) 15: 669Google Scholar
  67. 67.
    Kob D, Klötzer K-H, Arndt J, Stadie G (1980) Klinische Untersuchungen zum Problem der Vor- und Nachbestrahlung maligner Nierentumoren. Radiobiol Radiother (Berl) 21: 729Google Scholar
  68. 68.
    König HJ, Hartwich G (1980) Zytostatische Therapie des hypernephroiden Nierenkarzinoms. Dtsch Med Wochenschr 105: 1810PubMedCrossRefGoogle Scholar
  69. 69.
    Kurth KH, van der Werf-Messing B, Maksimovic PA (1983) Nierenkarzinom: Lokale Radiotherapie von Metastasen in der Wirbelsäule. Verh Dtsch Ges Urol 34. Tagung. Springer, Berlin Heidelberg New York, p 64Google Scholar
  70. 70.
    Lack EE, Cassady JR, Sallan SE (1985) Renal cell carcinoma in childhood and adolescence: a clinical and pathological study of 17 cases. J Urol 133: 822PubMedGoogle Scholar
  71. 71.
    Lieber MM, Tomera FM, Taylor WF, Farrow GM (1981) Renal adenocarcinoma in young adults: survival and variables affecting prognosis. J Urol 125: 164PubMedGoogle Scholar
  72. 72.
    Lieber MM, Kovach JS (1981) Soft agar clonogenic assay for primary human renal cell carcinoma: in vitro chemotherapeutic drug-sensitivity testing. Invest Urol 19: 111PubMedGoogle Scholar
  73. 73.
    von Lieven H, Lissner J (1977) Strahlentherapie beim Adenokarzinom der Niere. Strahlentherapie 153: 245Google Scholar
  74. 74.
    von Lieven H, Trott K-R, Sintermann R (1978) Experimentelle Ergebnisse der praoperativen Bestrahlung des renalen Adenokarzinoms. Strahlentherapie 154: 299Google Scholar
  75. 75.
    von Lieven H, Meister P, Keiditsch E (1978) Die Bedeutung des Differenzierungsgrades beim Adenokarcinom der Niere. MMW 120: 729Google Scholar
  76. 76.
    Lindner H (1981) Bestrahlungsplanung beim Nierenkarzinom. In: Schmiedt E, Bauer H-W (ed) Diagnostik und Therapie des Nierenkarzinoms. Zuckschwerdt, München, p 166Google Scholar
  77. 77.
    Lissner J (1974) Strahlentherapie bei Nierentumoren. Verh Dtsch Ges Urol 26. Tagung. Springer, Berlin Heidelberg New York, p 150Google Scholar
  78. 78.
    Ljungberg B, Stenling R, Roos G (1985) DNA content in renal cell carcinoma with reference to tumor hetero-geneity. Cancer 56: 503PubMedCrossRefGoogle Scholar
  79. 79.
    Maentylae M, Nordman E, Minkkinen J (1977) Post-operative radiotherapy of renal adenocarcinoma. Ann Clin Res 9: 252Google Scholar
  80. 80.
    Mau S, Rießbeck K-H, Mandel L, Coblenz R (1980) Ergebnisse der Kombinationstherapie maligner Nieren-tumoren. Radiobiol Radiother (Berl) 21: 271Google Scholar
  81. 81.
    McDonald MW (1982) Current therapy for renal cell carcinoma. J Urol 127: 211PubMedGoogle Scholar
  82. 82.
    McDonald MW, Diokno AC, Seski JC, Menon KM (1983) Measurement of progesterone receptor in human renal cell carcinoma and normal renal tissue. J Surg Oncol 22: 164PubMedCrossRefGoogle Scholar
  83. 83.
    McNichols DW, Segura JW, DeWeerd JH (1981) Renal cell carcinoma: long-term survival and late recurrence. J Urol 126: 17PubMedGoogle Scholar
  84. 84.
    Meister P (1981) Nierenkarzinom: Pathologische Anatomie. In: Schmiedt E, Bauer H-W (ed) Diagnostik und Therapie des Nierenkarzinoms. Zuckschwerdt, Muenchen, p 1Google Scholar
  85. 85.
    Murphy GP, Schirmer HK (1963) The diagnosis and treatment of hypernephroma. Geriatrics 18: 354PubMedGoogle Scholar
  86. 86.
    Murphy GP, Mostofi FK (1965) The significance of cytoplasmic granularity in the prognosis of renal cell carcinoma. J Urol 94: 48PubMedGoogle Scholar
  87. 87.
    Nakano E, Tada Y, Fujioka H, Matsuda M, Osafune M, Kotake T, Sato B, Takaha M, Sonoda T (1984) Hormone receptor in renal cell carcinoma and correlation with clinical response to endocrine therapy. J Urol 132: 240PubMedGoogle Scholar
  88. 88.
    Nickolisen R, Fallon B (1985) Locally recurrent hypernephroma treated by radiation therapy and embolisation. A report of two cases. Cancer 56: 1049PubMedCrossRefGoogle Scholar
  89. 89.
    Noecker D, Hobrecker M (1976) Therapieplanung und Prognosebeurteilung bei bosartigen Nierengeschwuelsten. Strahlentherapie 152: 498Google Scholar
  90. 90.
    Nurmi MJ (1984) Prognostic factors in renal carcinoma. An evaluation of operative findings. Br J Urol 56: 270PubMedCrossRefGoogle Scholar
  91. 91.
    Ochsner MG, Brannan W, Pond HS, Goodier EH (1973) Renal cell carcinoma: review of 26 years of experience at the Ochsner Clinic. J Urol 110: 643PubMedGoogle Scholar
  92. 92.
    Olver IN, Leavitt RD (1984) Chemotherapy and immunotherapy of disseminated renal cancer. In: Javadpour N (ed) Cancer of the kidney. Thieme-Stratton, New YorkGoogle Scholar
  93. 93.
    Otto U, Baisch H, Huland H, Kloppel G (1984) Tumor cell deoxyribonucleic acid content and prognosis in human renal cell carcinoma. J Urol 132: 237PubMedGoogle Scholar
  94. 94.
    Otto U, Huland H, Baisch H, Kloeppel G (1984) Transplantation of human renal cell carcinoma into NMRI NU NU mice. II. Evaluation of response to vinblastine sulfate monotherapy. J Urol 131: 134PubMedGoogle Scholar
  95. 95.
    Paces V, Poleckova V, Zamecnik J (1978) Preoperative irradiation of renal cell carcinoma in adults (controlled clinical trial). Int Urol Nephrol 10 (2): 77PubMedCrossRefGoogle Scholar
  96. 96.
    Palma LD, Kenney GM, Murphy GP (1970) Childhood renal carcinoma. Cancer 26: 1321PubMedCrossRefGoogle Scholar
  97. 97.
    Parienty RA, Richard F, Pradel J, Vallancien G (1984) Local recurrence after nephrectomy for primary renal cancer: computerized tomography recognition. J Urol 132: 246PubMedGoogle Scholar
  98. 98.
    Patel NP, Lavengood RW (1978) Renal cell carcinoma: natural history and results of treatment. J Urol 119: 722PubMedGoogle Scholar
  99. 99.
    Paulson DF, Perez CA, Anderson T (1985) Cancer of the kidney and the ureter. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer, principles and practice of oncology. Lippincott, Philadelphia, p 732Google Scholar
  100. 100.
    Pearson J, Friedmann MA, Hoffman PG (1981) Hormone receptors in renal cell carcinoma. Their utility as predictors of response to endocrine therapy. Cancer Chemother Pharmacol 6: 151PubMedCrossRefGoogle Scholar
  101. 101.
    Pizzocaro G, DiFronzo G, Piva L, Salvioni R, Ronchi E, Cappelleti V, Giongo A, Mastroberadino E, Cozzoli C, Dormia E, Minervini S, Zanollo A, Fontanella U, Giannoni R, Maggioni A, Lasio E (1983) Adjunctive medroxyprogesterone acetate to radical nephrectomy in category MO renal cell carcinoma. Eur Urol 9: 202PubMedGoogle Scholar
  102. 102.
    Pontes JE (1983) Adjunctive treatment of renal cell carcinoma. Int Adv Surg Oncol 6: 309PubMedGoogle Scholar
  103. 103.
    Possinger K, Hartenstein R, Ehrhart H (1981) Chemotherapie des Adenokarzinoms der Niere. In: Schmiedt E, Bauer H-W (eds) Diagnostik und Therapie des Nierenkarzinoms. Zuckschwerdt, Muenchen, p 183Google Scholar
  104. 104.
    Poster DS, Bruno S, Penta J, Pirna K, Vilk P, Macdonald J (1982) Current status of chemotherapy, hormonal therapy and immunotherapy in the treatment of renal cell carcinoma. Am J Clin Oncol 5: 53PubMedGoogle Scholar
  105. 105.
    Prignitz J, Popp FA, Scholz H (1973) Zur Optimierung der Bestrahlungsplanung in der 60-Co-Tiefentherapie. Überlegungen zur Einstelltechnik bei Nierenmalignomen. Strahlentherapie 145: 378PubMedGoogle Scholar
  106. 106.
    Rabes HM, Carl P, Meister P, Rattenhuber KU (1979) Analysis of proliferative compartments in human tumors. Cancer 44: 799PubMedCrossRefGoogle Scholar
  107. 107.
    Rabes HM (1981) Zellkinetik des Nierenkarzinoms. In: Schmiedt E, Bauer H-W (eds) Diagnostik und Therapie des Nierenkarzinoms. Zuckschwerdt, München, p 15Google Scholar
  108. 108.
    Rafla S (1970) Renal cell carcinoma. Natural history and results of treatment. Cancer 25: 26PubMedCrossRefGoogle Scholar
  109. 109.
    Rafla S, Parikh K (1984) The role of adjuvant radio-therapy in management of renal cell carcinoma. In: Javadpour N (ed) Cancer of the kidney. Thieme-Stratton, New YorkGoogle Scholar
  110. 110.
    Rahn H, Keiner P, Pinsler G (1982) Bestrahlungstechniken zur postoperativen Bestrahlung des Nierenkarzinoms. Radiobiol Radiother (Berl) 23: 551Google Scholar
  111. 111.
    Rhomberg W (1983) Zur Klinik und Strahlensensibilitaet von Knochenmetastasen bei Nierenkarzinomen. Strahlentherapie 159: 610PubMedGoogle Scholar
  112. 112.
    Riches EW (1966) The place of radiotherapy in the management of parenchymal carcinoma of the kidney. J Urol 95: 313PubMedGoogle Scholar
  113. 113.
    Riches EW (1968) Cancer of the urogenital tract: kidney. Localized renal adenocarcinoma. The place of irradiation. JAMA 204: 230PubMedCrossRefGoogle Scholar
  114. 114.
    Riches EW (1970) Preoperative irradiation of carcinoma of the kidney. In: Riches EW (ed) Modern trends in urology, vol 3. Butterworths, London, p 216Google Scholar
  115. 115.
    Richter E, Bohndorf W (1979) Behandlungsergebnisse bei hypernephroiden Karzinomen unter besonderer Berücksichtigung des Metastasenproblems. Strahlentherapie 155: 607PubMedGoogle Scholar
  116. 116.
    Ringleb D, Rommel K (1963) Zur radiologischen Klinik der Nierengeschwuelste Erwachsener. Strahlentherapie 121: 323Google Scholar
  117. 117.
    Ritchie AW, Kemp IW, Chisholm GD (1984) Is the incidence of renal carcinoma increasing? Br J Urol 56: 571PubMedCrossRefGoogle Scholar
  118. 118.
    Robson CJ, Churchill BM, Anderson W (1969) The results of radical nephrectomy for renal cell carcinoma. J Urol 101: 297PubMedGoogle Scholar
  119. 119.
    Robson CJ (1982) Results of radical thoraco-abdominal nephrectomy in the treatment of renal cell carcinoma. Prog Clin Biol Res 100: 481PubMedGoogle Scholar
  120. 120.
    Rodriguez LH, Johnson DE (1978) Clinical trial of cisplatinum (NSC 119875) in metastatic renal cell carci-noma. Urology 11: 344PubMedCrossRefGoogle Scholar
  121. 121.
    Röder K, Theuring F (1981) Strahlenbiologische Aspekte und morphologische Befunde nach Nierenvorbestrahlung. Radiobiol Radiother (Berl) 22: 609Google Scholar
  122. 122.
    Rohloff R, von Lieven H (1981) Die Rolle der Strahlentherapie bei der Behandlung des Adenokarzinoms der Niere. In: Schmiedt E, Bauer HW (ed) Diagnostik und Therapie des Nierenkarzinoms. Zuckschwerdt, MünchenGoogle Scholar
  123. 123.
    Rost A, Brosig W, Ernst H (1976) Die preoperative Bestrahlung beim hyper-nephroiden Karzinom. Helv Chir Acta 43: 309PubMedGoogle Scholar
  124. 124.
    Rübe W, Seegelken K (1974) Dickdarmstenosen nach Bestrahlung von Nierentumoren. Strahlentherapie 147: 63PubMedGoogle Scholar
  125. 125.
    Saitoh H, Hida M, Nakamura K, Shimbo T, Shiramizu T, Satoh T (1982) Metastatic processes and a potential indication of treatment for metastatic lesions of renal adenocarcinoma. J Urol 128: 916PubMedGoogle Scholar
  126. 126.
    Saksela E, Alfthan O, Malmio K (1973) Effect of pre-operative radiotherapy on the growth of human renal carcinoma tissue in vitro. Scand J Urol Nephrol 7: 181PubMedCrossRefGoogle Scholar
  127. 127.
    Samuels ML, Sullivan P, Howe CD (1968) Medroxy-progesterone acetate in treatment of renal cell carcinoma (hypernephroma). Cancer 22: 525PubMedCrossRefGoogle Scholar
  128. 128.
    Sarre H, Moser F (1961) Bestrahlungsfibrose, Bestrahlungsnephritis und isolierte Hypertonic nach Rontgen-bestrahlung der Niere. Dtsch Med J 12: 232PubMedGoogle Scholar
  129. 129.
    Satomi Y, Takai S, Kondo J, Fukushima S, Furuhata A (1982) Postoperative prophylactic use of progesterone in renal cell carcinoma. J Urol 128: 919PubMedGoogle Scholar
  130. 130.
    Scherer E (1980) Strahlentherapie, 2nd edn. Springer, Berlin Heidelberg New YorkGoogle Scholar
  131. 131.
    Schmidt CG (1976) Metastasierendes hypernephroides Nierenkarzinom. Dtsch Med Wochenschr 101: 347Google Scholar
  132. 132.
    Selli C, Hinshaw WM, Woodart BH, Paulson DF (1983) Stratification of risk factors in renal cell carcino-ma. Cancer 52: 899PubMedCrossRefGoogle Scholar
  133. 133.
    Sigel A, Chlepas S, Hermanek P, Herrlinger A (1981) Stagnation in der Therapie der Nierentumoren — Chancen einer Besserung. In: Schmiedt E, Bauer HW (eds) Diagnostik und Therapie des Nierenkarzinoms. Zuckschwerdt, München, p 109Google Scholar
  134. 134.
    Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF (1971) The diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer 28: 1165PubMedCrossRefGoogle Scholar
  135. 135.
    Skinner DG, Vermillion CD, Colvin RB (1972) The surgical management of renal cell carcinoma. J Urol 107: 705PubMedGoogle Scholar
  136. 136.
    Smith RB, DeKernion JB, Ehrlich RM, Skinner DG, Kaufmann II (1984) Bilateral renal cell carcinoma and renal cell carcinoma in the solitary kidney. J Urol 132: 450PubMedGoogle Scholar
  137. 137.
    Sparwasser C, Bach D, Sparwasser H, Altwein JE (1984) Das bilaterale Hypernephrom. Kritische Ubersicht und eigenes Therapiekonzept. Akt Urol 15: 312CrossRefGoogle Scholar
  138. 138.
    Standke E, Ölßner W, Melzer R (1984) CT-gestützte Bestrahlungsplanung der Nierentumoren. Radiobiol Radiother (Berl) 25: 361Google Scholar
  139. 139.
    Steinberg SM, Brodovsky HS, Goepp CE (1972) Renal carcinoma in mother and daughter. Cancer 29: 222PubMedCrossRefGoogle Scholar
  140. 140.
    Stender HS, Berndt G (1968) Strahlenbehandlung von Tumoren der Nieren und des Nierenbeckens. Röntgenblatter 21: 69Google Scholar
  141. 141.
    Strietzel M, Ziegler P-G, Hamann D, Kittner KH, Hildebrandt K-H, Bast R (1984) Beitrag zur Strahlenbe-handlung maligner Nierentumoren. Radiobiol Radiother (Berl) 25: 383Google Scholar
  142. 142.
    Väth JM (1973) Cancer of the kidney - radiation therapy and its indications in non-Wilms’ tumors. Cancer 23: 1053CrossRefGoogle Scholar
  143. 143.
    Vergau W, Buerkle G, Herzer R, Sadowski P (1972) Dünndarmschädigung der Telekobalt-Pendelbestrahlung der Nierenregion. Strahlentherapie 144: 697PubMedGoogle Scholar
  144. 144.
    Vermillion CD, Skinner DG, Pfister RC (1972) Bilateral renal cell carcinoma. J Urol 108: 219PubMedGoogle Scholar
  145. 145.
    Voss AC, Wöllgens P, Klöckner D (1974) Das hyper-nephroide Karzinom. Methodik und Ergebnisse der postoperativen Radiotherapie bei 223 Patienten. Strahlentherapie 147: 447PubMedGoogle Scholar
  146. 146.
    Wagle DG, Moore RH, Murphy GP (1975) Secondary carcinomas of the kidney. J Urol 114: 30–32PubMedGoogle Scholar
  147. 147.
    Wagle DG, Seal DR (1970) Renal cell carcinoma — a review of 256 cases. J Surg Oncol 2: 23–32PubMedCrossRefGoogle Scholar
  148. 148.
    Waters CA, Lewis LG, Frontz WA (1934) Radiation therapy of renal cortical neoplasms, with special reference to preoperative irradiation. South Med J 27: 290CrossRefGoogle Scholar
  149. 149.
    Waters WB, Richie IP (1979) Aggressive surgical approach to renal cell carcinoma. Review of 130 cases. J Urol 122: 306PubMedGoogle Scholar
  150. 150.
    Wehbe S (1978) Duodenalstenosen nach Bestrahlung der Nierenregion wegen Malignom. Fortschr Geb Roentgenstr 129: 421CrossRefGoogle Scholar
  151. 151.
    Weissmüller J, Herrlinger A, von Maillot K (1983) Wert der Rezeptor-Bestimmung und der Hormontherapie beim metastasierenden Hypernephrom. Verh Dtsch Ges Urol, 34. Tagung. Springer, Berlin Heidelberg New YorkGoogle Scholar
  152. 152.
    van der Werf-Messing B (1973) Carcinoma of the kidney. Cancer 32: 1056PubMedCrossRefGoogle Scholar
  153. 153.
    van der Werf-Messing B (1974) La place de la radio-therapie dans le traitement du cancer du rein et du cancer de la prostate chez l’adulte: Carcinome du rein. Un essai therapeutique. J Radiol Electrol 55: 785Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • R.-D. Müller
  • E. Scherer
  • C. Wirtz

There are no affiliations available

Personalised recommendations